CanChip

CanChip is at the forefront of biotechnology research, revolutionizing cancer treatment development with its innovative tumor-on-a-chip technology. Overcoming the limitations of traditional models, CanChip authentically replicates the tumor microenvironment, significantly accelerating drug screening processes. The company's expertise in designing tracheal tumor chips not only enhances efficiency and accuracy but also fosters collaboration with leading universities.

Located at Am Mühlenberg 10, 14476 Potsdam, DE, CanChip is paving the way for personalized cancer treatment strategies through advanced microfluidics and comprehensive genomics research. By providing cutting-edge consulting services and simulation of metastasis, CanChip empowers researchers and clinicians to gain deeper insights into cancer biology and develop more effective therapies.

CanChip is committed to transforming the landscape of cancer research through continuous innovation and strategic partnerships. The company’s dedication to biomarker expression profiling, microenvironment interaction studies, and 3D cell culture ensures that it remains a key player in the fight against cancer. We invite the manager of CanChip to create a customized and exclusive company showcase and product listing on our platform to further enhance your commercial development.